|本期目录/Table of Contents|

[1]张小青,徐延敏.血浆corin、NEP、BNP与心功能衰竭及左室收缩功能的相关性[J].天津医科大学学报,2019,25(06):623-626.
　ZHANG Xiao-qing,XU Yan-min.Serum corin, NEP and BNP in patients with heart failure and its correlation with left ventricle systolic function[J].Journal of Tianjin Medical University,2019,25(06):623-626.
点击复制

血浆corin、NEP、BNP与心功能衰竭及左室收缩功能的相关性(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
25卷
期数:
2019年06期
页码:
623-626
栏目:
临床医学
出版日期:
2019-11-20

文章信息/Info

Title:
Serum corin, NEP and BNP in patients with heart failure and its correlation with left ventricle systolic function
文章编号:
1006-8147(2019)06-0623-04
作者:
张小青; 徐延敏
（天津医科大学第二医院心内科，天津 300211）
Author(s):
ZHANG Xiao-qing; XU Yan-min
（Department of Cardiology, The Second Hospital, Tianjin Medical University, Tianjin 300211,China）
关键词:
心功能衰竭; 左室射血分数; corin; B型利钠肽; ELISA
Keywords:
heart failure; LVEF; corin; Brain Natriuretic Peptide; ELISA
分类号:
R541.6
DOI:
-
文献标志码:
A
摘要:
目的：探讨血浆corin、脑啡肽酶（NEP）、B型利钠肽（BNP）在慢性心功能衰竭患者病情评估中的临床价值及其与左心室收缩功能的相关性。方法：选取2016年1月-2018年1月在我院心内科就诊的患者为研究对象，根据患者心衰评分及EF值分组：无心衰正常EF组（nEF对照组），无心衰收缩功能减低组（rEF+nHF，rEF≤50%），和收缩功能减低心衰组（rEF+dHF，rEF≤50%），每组32例。采用酶联免疫吸附法检测各组血浆corin、NEP、BNP浓度，并比较分析其变化情况。结果：一般临床资料组间比较无差别（P>0.05）。EF减低组血清corin浓度均明显低于nEF对照组（P <0.05），而血清NEP、BNP浓度均明显高于nEF对照组（P <0.05）。血浆corin和NEP浓度呈负相关关系。多元线性回归分析血浆corin水平是LVEF的独立风险因素。结论：血浆corin、NEP、BNP水平与心衰患者心脏收缩功能变化有关，监测血浆corin水平有望为心衰的治疗提供新的思路。
Abstract:
Objective: The aim of the study was to evaluate the clinical value of serum corin, NEP and BNP in patients with chronic heart failure and its correlation with left ventricle systolic function. Methods：Patients admitted to the department of cardiology were eligible for the study from January 2016 to January 2018. Patients were divided into 3 groups according to the Framingham heart failure criteria and ejection fraction (EF), namely, no HF and normal EF (nEF control group), no HF and systolic dysfunction (rEF≤50%) (rEF+nHF group), and HF with systolic dysfunction(rEF≤50%) (rEF+dHF group), 32 patients in each group. The serum corin, NEP and BNP levels were measured by ELISA, and their difference among the groups were analyzed. Results：There was no statistically significant difference in the general characteristics among the groups (P >0.05). Serum corin level in rEF group was significantly lower than that of nEF control group (P <0.05), while serum NEP and BNP levels were significantly higher than those of nEF control group(P <0.05). There was a negative correlation between serum corin and NEP levels. Multivariate linear regression analysis showed that plasma corin level was an independent factor of LVEF. Conclusion： Serum corin, NEP and BNP levels were related to cardiac systolic function in patients with heart failure. Measuring serum corin level may provide a new idea for the treatment of heart failure.

参考文献/References:

[1] Bayes-Genis A, Barallat J, Richards A M. A test in context: neprilysin function, inhibition, and biomarker[J]. J Am Coll Cardiol, 2016,68(6): 639
[2] Tripathi R, Wang D, Sullivan R, et al. Depressed corin levels indicate early systolic dysfunction before increases of atrial natriuretic peptide/B-Type natriuretic peptide and heart failure development[J]. Hypertension, 2016, 67(2):362
[3] Dries D L. Process matters emerging concepts underlying impaired natriuretic peptide system function in heart failure[J]. Circ Heart Fail, 2011,4(2):107
[4] Bayes-Genis A, Barallat J, Galan A, et al. Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients[J]. J Am Coll Cardiol, 2015,65(7):657
[5] 戴震国, 杨爽, 于波. Corin在心血管领域的研究进展[J].心血管康复医学杂志,2017,26(2):217
[6] Galinier M, Cariou E, Lairez O, et al. Place of natriuretic peptides in the early diagnosis of heart failure in community medicine[J]. Presse Medicale, 2018,47(9):804
[7] Bhatt A S, Cooper L B, Ambrosy A P, et al. Interaction of body mass index on the association between N-Terminal-Pro-b-Type natriuretic peptide and morbidity and mortality in patients with acute heart failure: findings from ASCEND-HF (acute study of clinical effectiveness of nesiritide in decompens[J]. J Am Heart Assoc, 2018,7(3):6740
[8] Nordberg R C, Wang H, Wu Q Y, et al. Corin is a key regulator of endochondral ossification and bone development via modulation of vascular endothelial growth factor A expression[J]. J Tissue Eng Regen Med, 2018,12(12):2277
[9] Pamukeu H E, Uludag D M, Tak B T, et al. Evaluation of the effect of non-ergot dopamine agonists on left ventricular systolic function with speckle tracking echocardiography[J]. Anatol J Cardiol , 2018, 20(4): 213
[10] Verstreken S, Delrue L, Goethals M, et al. Natriuretic peptide processing in patients with and without left ventricular dysfunction[J]. Int Heart J, 2019,60(1):115
[11] Jiang J J, Zhou Q, Sun M C, et al. Corin is highly expressed in atherosclerosis models[J]. Biochem Biophys Res Commun,2018, 504(2):440
[12] Wang D, Gladysheva I P, Sullivan R D, et al. Increases in plasma corin levels following experimental myocardial infarction reflect the severity of ischemic injury[J]. PLoS One, 2018,13(9): e0202571
[13] Lee R, Xu B, Rame J E, et al. Regulated inositol-requiring protein 1-dependent decay as a mechanism of corin RNA and protein deficiency in advanced human systolic heart failure[J]. J Am Heart Assoc, 2014:e001104
[14] Rubattu S, Forte M, Marchitti S, et al. Molecular implications of natriuretic peptides in the protection from hypertension and target organ damage development [J]. Int J Mol Sci, 2019, 20(4): pii: E798
[15] Balc?覦 K G, Balc?覦 M M. Echogenicity and echocardiographic guidance[J]. Anatol J Cardiol, 2019, 21(3):177

相似文献/References:

[1]刘运龄,赵艳淑,刘恩照,等.不同类型心房颤动患者心脏结构及B型钠尿肽水平的变化[J].天津医科大学学报,2016,22(06):522.
　LIU Yun-ling,ZHAO Yan-shu,LIU En-zhao,et al.Relationship between plasma leves B-type natriuretic peptide and cardiac structure in patients with different types of atrial fibrillation[J].Journal of Tianjin Medical University,2016,22(06):522.

备注/Memo

备注/Memo:
作者简介 张小青（1978-），男，硕士在读，研究方向：心内科；通信作者：徐延敏，E-mail: xuyanminphdmd@sina.com。
更新日期/Last Update: 2020-01-20